Jinjin Shi

8.7k total citations · 2 hit papers
189 papers, 6.8k citations indexed

About

Jinjin Shi is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Jinjin Shi has authored 189 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Biomedical Engineering, 66 papers in Molecular Biology and 42 papers in Biomaterials. Recurrent topics in Jinjin Shi's work include Nanoplatforms for cancer theranostics (71 papers), Nanoparticle-Based Drug Delivery (39 papers) and Advanced biosensing and bioanalysis techniques (32 papers). Jinjin Shi is often cited by papers focused on Nanoplatforms for cancer theranostics (71 papers), Nanoparticle-Based Drug Delivery (39 papers) and Advanced biosensing and bioanalysis techniques (32 papers). Jinjin Shi collaborates with scholars based in China, New Zealand and United States. Jinjin Shi's co-authors include Kaixiang Zhang, Junjie Liu, Zhenzhong Zhang, Hongling Zhang, Zhenzhong Zhang, Lei Wang, Lihua Xu, Sixuan Wu, Binghua Wang and Zhenzhong Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.

In The Last Decade

Jinjin Shi

184 papers receiving 6.7k citations

Hit Papers

Advances of nanoparticles as drug delivery systems for di... 2022 2026 2023 2024 2022 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinjin Shi China 49 3.4k 2.3k 1.9k 1.6k 541 189 6.8k
Xin Li China 50 3.0k 0.9× 2.7k 1.2× 1.6k 0.8× 2.4k 1.5× 383 0.7× 352 8.6k
Yiguang Wang China 51 3.3k 1.0× 3.3k 1.5× 3.0k 1.5× 2.4k 1.5× 487 0.9× 215 9.9k
Hongling Zhang China 41 2.0k 0.6× 1.5k 0.6× 1.1k 0.6× 1.1k 0.7× 346 0.6× 167 5.0k
Fang Chen China 49 3.2k 0.9× 2.5k 1.1× 1.5k 0.8× 3.0k 1.8× 288 0.5× 184 8.3k
Xin Zhang China 51 2.0k 0.6× 3.5k 1.5× 1.1k 0.6× 1.7k 1.0× 315 0.6× 224 7.7k
Feng Wang China 45 2.8k 0.8× 2.3k 1.0× 2.0k 1.0× 1.8k 1.1× 227 0.4× 205 7.0k
Teng Liu China 38 5.2k 1.5× 2.1k 0.9× 4.4k 2.3× 1.6k 1.0× 533 1.0× 151 8.9k
Wen‐Fei Dong China 54 4.3k 1.2× 2.4k 1.1× 4.2k 2.2× 2.4k 1.5× 374 0.7× 259 9.9k
Jie Li China 47 3.6k 1.1× 1.8k 0.8× 2.2k 1.1× 1.1k 0.7× 803 1.5× 171 6.7k

Countries citing papers authored by Jinjin Shi

Since Specialization
Citations

This map shows the geographic impact of Jinjin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjin Shi more than expected).

Fields of papers citing papers by Jinjin Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjin Shi. The network helps show where Jinjin Shi may publish in the future.

Co-authorship network of co-authors of Jinjin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Jinjin Shi. A scholar is included among the top collaborators of Jinjin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinjin Shi. Jinjin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Binghua, et al.. (2026). A softness zwitterionic micelles efficiently deliver inhaled nintedanib by enhancing airway mucus penetration. Science Advances. 12(1). eady1030–eady1030.
2.
Xiang, T., Danyu Wang, Jing Wang, et al.. (2025). Locally producing antibacterial peptide to deplete intratumoral pathogen for preventing metastatic breast cancer. Acta Pharmaceutica Sinica B. 15(2). 1084–1097. 4 indexed citations
3.
Shi, Jinjin, Yanjun Liu, Changyun Li, et al.. (2024). Unraveling the role of ubiquitin-conjugating enzyme 5 (UBC5) in disease pathogenesis: A comprehensive review. Cellular Signalling. 124. 111376–111376. 3 indexed citations
4.
Yang, Guan‐Jun, Yanjun Liu, Jinjin Shi, et al.. (2024). PRMT7 in cancer: Structure, effects, and therapeutic potentials. European Journal of Medicinal Chemistry. 283. 117103–117103. 2 indexed citations
5.
Yang, Jiali, Mingzhu Yang, Wei Liu, et al.. (2024). Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and H2S scavenging for colitis treatment. Journal of Controlled Release. 374. 140–153. 15 indexed citations
6.
Liu, Yanjun, et al.. (2024). Evaluation on the antibacterial activity of glycyrrhizin against Pseudomonas plecoglossicida in ayu fish (Plecoglossus altivelis). Aquaculture. 595. 741520–741520. 2 indexed citations
7.
Yin, Na, Wenya Wang, Fei Pei, et al.. (2024). A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment. Advanced Science. 11(17). e2305877–e2305877. 21 indexed citations
8.
Ding, Lijian, Yanjun Liu, Jinjin Shi, et al.. (2024). Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer. Marine Drugs. 22(10). 459–459. 2 indexed citations
9.
Zhou, Lei, Mengyao Wang, Qi Xu, et al.. (2024). Dendritic Cell‐Hitchhiking In Vivo for Vaccine Delivery to Lymph Nodes. Advanced Science. 11(33). e2402199–e2402199. 6 indexed citations
10.
Li, Changyun, Y. Liu, Tao Fan, et al.. (2023). Lysine-specific demethylase 7A (KDM7A): A potential target for disease therapy. Biochemical Pharmacology. 216. 115799–115799. 6 indexed citations
11.
Xiang, T., Yunya Zhang, Hongling Zhang, et al.. (2023). Safe engineering of cancer-associated fibroblasts enhances checkpoint blockade immunotherapy. Journal of Controlled Release. 356. 272–287. 20 indexed citations
12.
Wang, Zhi‐Hao, Wanting Huang, Shuhao Zhang, et al.. (2023). Self‐Thermophoretic Nanoparticles Enhance Intestinal Mucus Penetration and Reduce Pathogenic Bacteria Interception in Colorectal Cancer. Advanced Functional Materials. 33(17). 37 indexed citations
13.
Liang, Yan, Jinjin Wang, Sixuan Wu, et al.. (2023). Remodeling Collagen Microenvironment in Liver Using a Biomimetic Nano‐Regulator for Reversal of Liver Fibrosis. Advanced Science. 10(18). e2300127–e2300127. 14 indexed citations
14.
Zhao, Xiu, Jun Li, Zhenzhong Zhang, et al.. (2023). Recent Progress on High‐Z Metal‐Based Nanomaterials for Cancer Radiosensitization. Chinese Journal of Chemistry. 41(19). 2545–2556. 10 indexed citations
16.
Zhao, Xiu, Hui Cheng, Weimin Nie, et al.. (2023). Regulating Photosensitizer Metabolism with DNAzyme-Loaded Nanoparticles for Amplified Mitochondria-Targeting Photodynamic Immunotherapy. ACS Nano. 17(14). 13746–13759. 35 indexed citations
17.
Guo, Jialing, Di Huang, Xiu Zhao, et al.. (2023). Genotype-specific precision tumor therapy using mitochondrial DNA mutation-induced drug release system. Science Advances. 9(39). eadi1965–eadi1965. 18 indexed citations
18.
Wu, Sixuan, Kaixiang Zhang, Yan Liang, et al.. (2021). Nano‐enabled Tumor Systematic Energy Exhaustion via Zinc (II) Interference Mediated Glycolysis Inhibition and Specific GLUT1 Depletion. Advanced Science. 9(7). e2103534–e2103534. 117 indexed citations
19.
Li, Yanyan, Wei Liu, Kaixiang Zhang, et al.. (2019). Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor. Journal of Nanobiotechnology. 17(1). 117–117. 27 indexed citations
20.
Liu, Hongbo, et al.. (2014). [Reconstructing habitat history of Larimichthys polyactis in Lüsi coastal waters of Jiangsu Province, China based on otolith microchemistry].. PubMed. 25(3). 836–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026